CARDLYTICS, INC.
Income Statement
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $233.3M | $278.3M | $309.2M | $298.5M | $267.1M | $186.9M | $210.4M |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | — | $39.8M | $49.6M | $51.4M | $54.4M | $38.1M | $17.5M | $11.7M |
| SG&A Expense | — | $47.3M | $56.5M | $58.8M | $81.4M | $66.2M | $46.5M | $36.7M |
| Operating Income | — | $-101.8M | $-195.5M | $-135.7M | $-457.8M | $-122.6M | $-53.9M | $-17.3M |
| Operating Margin | — | -43.6% | -70.2% | -43.9% | -153.3% | -45.9% | -28.9% | -8.2% |
| Interest Expense | — | — | — | $3.8M | $3.8M | $12.7M | $3.3M | — |
| Pretax Income | — | $-103.5M | $-189.3M | $-134.7M | $-466.7M | $-136.4M | $-55.4M | $-17.1M |
| Income Tax Expense | — | $0 | $0 | $0 | $-1.4M | $-7.9M | $0 | $0 |
| Net Income | — | $-103.5M | $-189.3M | $-134.7M | $-465.3M | $-128.6M | $-55.4M | $-17.1M |
| Net Margin | — | -44.4% | -68.0% | -43.6% | -155.8% | -48.1% | -29.7% | -8.1% |
| EPS (Basic) | — | $-1.95 | $-3.91 | $-3.69 | $-13.92 | $-3.99 | $-2.04 | $-0.72 |
| EPS (Diluted) | — | $-1.95 | $-3.91 | $-3.69 | $-13.92 | $-3.99 | $-2.04 | $-0.72 |
| Shares Outstanding (Basic) | 55.1M | 53.1M | 48.4M | 36.5M | 33.4M | 32.2M | 27.2M | 22.5M |
| Shares Outstanding (Diluted) | 55.1M | 53.1M | 48.4M | 36.5M | 33.4M | 32.2M | 27.2M | 22.5M |
| Dividends Per Share | — | — | — | — | — | — | — | — |